InvestLens › ASX companies
CSL Limited (CSL)
Plain-English briefings on CSL Limited's ASX announcements: what happened, what changed and why it matters, with links to the company's own documents.
Get an email with a plain-English briefing when it announces results or price-sensitive news. New accounts get Plus free for 14 days, with no card.
Latest developments
No change reports on CSL Limited yet. Follow it to get the first one.
Coming up
- Results: Around February 2027 (estimate). Expected results, about six months after the last on 17 Aug 2026
Dates come from market data and can change.
About CSL Limited
CSL Limited (ASX: CSL.AX) is a Melbourne-headquartered biopharmaceutical and vaccines company. It was founded in 1916 as Commonwealth Serum Laboratories and renamed CSL Limited in October 1991. Per the Yahoo Finance profile, it has three segments:
- CSL Behring: plasma products, gene therapies and recombinants.
- CSL Seqirus: influenza vaccines and pandemic-preparedness services for governments.
- CSL Vifor: iron deficiency and nephrology products.
From our research report of 31 Oct 2026. Sign up free to read all of it: recent results, the bull and bear cases, key risks and sources.